Postoperative photodynamic therapy as a new adjuvant treatment after robot-assisted salvage surgery of recurrent squamous cell carcinoma of the base of tongue.

Journal: World journal of surgical oncology
Published Date:

Abstract

BACKGROUND: For patients who remain with involved resection margins after transoral robot-assisted salvage surgery (TORS) for recurrent squamous cell carcinoma (SCC) at the base of tongue (BOT) following primary (chemo)radiotherapy, further adjuvant treatment options are very limited. We want to report on our preliminary experience with a new adjuvant strategy using postoperative temoporfin-mediated photodynamic therapy for this indication.

Authors

  • Vincent Vander Poorten
    Otorhinolaryngology-Head and Neck Surgery University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. vincent.vanderpoorten@uzleuven.be.
  • Jeroen Meulemans
    Otorhinolaryngology-Head and Neck Surgery University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.
  • Sandra Nuyts
    Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Paul Clement
    Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Robert Hermans
    Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Esther Hauben
    Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Pierre Delaere
    Otorhinolaryngology-Head and Neck Surgery University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.